Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen

The window period in hepatitis C virus (HCV) infection is still a major problem in ensuring blood safety. HCV RNA detection by nucleic acid amplification technology-based tests has contributed to reduce the infectivity of blood products, but it is expensive, time-consuming and affected by a high pre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Icardi, Giancarlo, Ansaldi, Filippo, Bruzzone, Bianca Marisa, Durando, Paolo, Lee, Stephen, de Luigi, Carla, Crovari, Pietro
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2001
Matèries:
Virology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC88305/
https://ncbi.nlm.nih.gov/pubmed/11526137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.39.9.3110-3114.2001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars